We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Technology

Audoo

Status: Unknown

Feb 10th 2020 - Apr 4th 2020

Audoo is a technology company that is revolutionising the music royalty industry. The company is working to ensure artists, composers, publishers and labels are fully acknowledged, recognised, and compensated for the broadcasting of their works. This is done through Audoo's 'Audiometer' that captures, analyses, and reports the music broadcasted in public areas, such as shops, gyms, restaurants, and bars. In 2019, the company joined Abbey Road Red, Europe’s first bespoke music & technology incubator. With the proceeds, the company will improve its fingerprinting database and Audio Meter hardware. It will also expand its business development team and technical team. 

read more read less

Audoo Rating Review

Rated on 25/02/2020

Pitch Rated

46%

Insufficient Data

Management

76%

Product

61%

Investment

UNRATED*

* Section unrated owing to insufficient or incomplete information available at the time of rating.

Pitch rating powered by CROWDRATING

What the ratings mean

  • 49% and under
    We suggest potential investors carry out further study of their own
    50-64%
    Room for improvement
    65-79%
    Worth considering
    80%+
    Gold rating, our highest rating
Click here for more information on our ratings
Login to view the full report

Management 76%

Skills 91%
Audoo has a team that is highly skilled and has expertise covering the functional areas of sales, marketing, operations and technology. They have a founder who was part of a multi-award-winning team and has been working in the technology sector for over five years. He has suitable experience and has built a strong team, which is the essence of a successful business.

0 comments

Log in to comment


Funding progress



More from Technology

Coinrule is a smart assistant designed for millennials looking to automate their investments in cryptocurrencies, financial assets and build trading strategies without having to program a single line of code. The platform empowers regular traders and investors to compete with professional algorithmic traders and hedge funds. Users can pick 'building blocks' via a simple interface to create trading strategies which also get backtested on historical data. The company aims to make trading an accessible option for all. It has 13,000+ registered users on its portal, witnessed a $3.3 million Monthly Trading Volume (MTV) in July 2020 despite the COVID-19 pandemic, and raised a pre-seed of £200,000 from MKB Bank and two Angel Investors (AI) in 2019. It also won the ‘Best for Beginners 2020’ award by Cryptotrader. The company will use the investment to become a reliable investment ecosystem for users, activate paid growth channels based on influencer marketing and direct acquisition, validate upcoming product offerings, and keep building a strong interdisciplinary team.
pledged: 107% days to go: 39 investment: £269,451
Themis is a Regulatory Technology (RegTech) company that helps organisations mitigate the risk and impact of all forms of financial crime such as money laundering, bribery, corruption, cybercrime, theft, slavery/human trafficking, and fraud. The RegTech sector is expected to become a GBP 10 billion industry at the end of 2020. Themis aims to be a major contender in this segment and also plans to stop financial frauds that it asserts costs companies globally GBP 3.2 trillion every year. The platform is designed to provide insights on the latest threats, trends, and criminal techniques whilst helping clients complete due diligence on their clients, staff, and supply chains. Themis's key clients include Dow Jones, TSB, Fiserv, Mitmark, Ebury, Natwest Group, Acuris, Glasswall, Evolution AI, and Kingley Napley amongst others. The company envisages exiting via an Initial Public Offering (IPO) or selling to a technology company or to a big consultancy wanting to have a specialized Financial Crime (FC) arm to their business, including a RegTech solution
pledged: 37% days to go: 85 investment: £567,027
Invisage is a cloud-based platform that helps asset managers optimise their performance and research costs by identifying the true value of investment research. The company asserts that Directive 2014/65/EU has led to the investment research market falling from $16.5 billion to $14 billion as managers look to reduce costs and increase value. Invisage asserts that its platform helps asset managers identify, objectively measure ‘value’ added by research, and consume only high-impact research. The company also offers a web-based research consolidation, valuation and attribution solution that gives a quantitative assessment of value added by research to client portfolios. Invisage will use the investment to enhance deep learning-based Natural Language Processing (NLP) models that detect the implicit ideas from research narrative, build partnerships with data providers and other solution providers, and market scale its sales function
pledged: 75% days to go: 85 investment: £75,000
Superpow! is an online therapy platform that intends to shift away from the conventional and clinical form of mental health treatment. It is a platform that aims to help users find a matching therapist based on factors such as preferred language, ethnical background, sexual orientation, gender, age, symptoms. The app endeavours to match a user with a therapist quicker than any other app. The company estimates that 70 million workdays are lost each year due to mental health problems in the UK, costing employers approximately £2.4 billion per year. This scenario is further exacerbated due to COVID-19. Superpow! aims to change this situation. It will use the investment to finalise app development, scale the business within the UK as well as Europe, and enter the US market.
pledged: 46% days to go: 22 investment: £23,335
Phlo is a digital pharmacy portal. Founder Nadeem Sarwar launched Phlo in 2019 after having faced the challenges with obtaining prescription medication from retail stores where there was either no stock or long waiting times. Phlo aims to become the UK’s leading on-demand 'Digital Pharmacy' platform. It is integrated with the National Health Service's (NHS) accredited systems and enables patients living within the London area to order and receive their medication within a 4-hour window. Phlo serves more than 4000 patients from Orkney to Jersey. It has received a 5- star rating on Trustpilot and secured a contract with Babylon, a leading UK-based telemedicine provider. Phlo will use the investment to grow its business across different verticals and become one of the UK’s leading digital pharmacies.
pledged: 110% days to go: 22 investment: £1,815,580

  • £215,417
    pledged
  • 86%
    of goal

    £250,026
    target

    £6,000,619
    pre-money valuation

    4.00%
    equity available

    54
    investors

    £3,989
    pledge per investor

    21/08/2018
    incorporated 2 years

    Equity Calculator
    Investment
    £
    Equity
    %
    Previous Funding rounds
    10 Feb 20 Seedrs £215,417 / 86% 45.67%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph